← Back to Discover
Ghost Tree Capital, LLC
Period ended Sep 30, 2024 · Latest filing Nov 14, 2024
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2024: $331,044,132
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2024. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- SPDR SER TR · S&P BIOTECH · 78464A870 · shares · PUT: $29,640,000
- BIOHAVEN LTD · CALL · G1110E907 · shares: $17,428,437
- SAREPTA THERAPEUTICS INC · COM · 803607100 · shares: $14,986,800
- NOVO-NORDISK A S · ADR · 670100205 · shares: $13,097,700
- BLUEPRINT MEDICINES CORP · COM · 09627Y109 · shares: $12,950,000
- AXSOME THERAPEUTICS INC · COM · 05464T104 · shares: $12,132,450
- TARSUS PHARMACEUTICALS INC · COM · 87650L103 · shares: $11,511,500
- PERSPECTIVE THERAPEUTICS INC · COM NEW · 46489V302 · shares: $10,012,500
- CG ONCOLOGY INC · COM · 156944100 · shares: $9,432,500
- ROIVANT SCIENCES LTD · SHS · G76279101 · shares: $9,232,000
Reported holdings
54 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| SPDR SER TR | S&P BIOTECH | 78464A870 | PUT | 300,000 shares | $29,640,000 |
| BIOHAVEN LTD | CALL | G1110E907 | — | 348,778 shares | $17,428,437 |
| SAREPTA THERAPEUTICS INC | COM | 803607100 | — | 120,000 shares | $14,986,800 |
| NOVO-NORDISK A S | ADR | 670100205 | — | 110,000 shares | $13,097,700 |
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | — | 140,000 shares | $12,950,000 |
| AXSOME THERAPEUTICS INC | COM | 05464T104 | — | 135,000 shares | $12,132,450 |
| TARSUS PHARMACEUTICALS INC | COM | 87650L103 | — | 350,000 shares | $11,511,500 |
| PERSPECTIVE THERAPEUTICS INC | COM NEW | 46489V302 | — | 750,000 shares | $10,012,500 |
| CG ONCOLOGY INC | COM | 156944100 | — | 250,000 shares | $9,432,500 |
| ROIVANT SCIENCES LTD | SHS | G76279101 | — | 800,000 shares | $9,232,000 |
| VAXCYTE INC | COM | 92243G108 | — | 80,000 shares | $9,141,600 |
| VIKING THERAPEUTICS INC | COM | 92686J106 | — | 140,000 shares | $8,863,400 |
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | — | 450,000 shares | $8,662,500 |
| JANUX THERAPEUTICS INC | COM | 47103J105 | — | 190,000 shares | $8,631,700 |
| ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | — | 52,500 shares | $7,838,775 |
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | — | 150,000 shares | $7,665,000 |
| SOLENO THERAPEUTICS INC | COM | 834203309 | — | 150,000 shares | $7,573,500 |
| TG THERAPEUTICS INC | COM | 88322Q108 | — | 310,000 shares | $7,250,900 |
| REZOLUTE INC | COM NEW | 76200L309 | — | 1,474,995 shares | $7,153,726 |
| PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | — | 375,000 shares | $6,780,000 |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | — | 128,411 shares | $6,474,483 |
| OLEMA PHARMACEUTICALS INC | COM | 68062P106 | — | 535,000 shares | $6,387,900 |
| IMMUNOVANT INC | COM | 45258J102 | — | 215,000 shares | $6,129,650 |
| INSMED INC | COM PAR $.01 | 457669307 | — | 75,000 shares | $5,475,000 |
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | — | 195,000 shares | $5,204,550 |
| REPLIMUNE GROUP INC | COM | 76029N106 | — | 450,000 shares | $4,932,000 |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | PUT | 220,000 shares | $4,538,600 |
| BRIDGEBIO PHARMA INC | COM | 10806X102 | — | 175,000 shares | $4,455,500 |
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | — | 2,150,000 shares | $4,321,500 |
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | — | 78,842 shares | $4,130,532 |
| ANNEXON INC | COM | 03589W102 | — | 650,000 shares | $3,848,000 |
| KORRO BIO INC | COM | 500946108 | — | 110,000 shares | $3,676,200 |
| INSMED INC | COM PAR $.01 | 457669307 | CALL | 50,000 shares | $3,650,000 |
| DYNE THERAPEUTICS INC | COM | 26818M108 | — | 100,000 shares | $3,592,000 |
| ARVINAS INC | COM | 04335A105 | — | 145,000 shares | $3,571,350 |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | — | 160,000 shares | $3,300,800 |
| HELIX ACQUISITION CORP II | CL A ORD SHS | G4444H101 | — | 300,000 shares | $3,134,988 |
| NUVATION BIO INC | COM CL A | 67080N101 | — | 1,350,000 shares | $3,091,500 |
| SAVARA INC | COM | 805111101 | — | 725,000 shares | $3,074,000 |
| TENAYA THERAPEUTICS INC | COM | 87990A106 | — | 1,500,000 shares | $2,895,000 |
| REGENXBIO INC | COM | 75901B107 | — | 265,000 shares | $2,779,850 |
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | — | 500,000 shares | $2,640,000 |
| ABSCI CORPORATION | COM | 00091E109 | — | 550,000 shares | $2,101,000 |
| NEUROGENE INC | COM | 64135M105 | — | 50,000 shares | $2,098,000 |
| CAPRICOR THERAPEUTICS INC | COM NEW | 14070B309 | — | 125,000 shares | $1,901,250 |
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | — | 65,000 shares | $1,874,600 |
| SUMMIT THERAPEUTICS INC | COM | 86627T108 | — | 85,000 shares | $1,861,500 |
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | — | 60,000 shares | $1,764,600 |
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | — | 75,000 shares | $1,706,250 |
| PROQR THRAPEUTICS N V | SHS EURO | N71542109 | — | 887,700 shares | $1,615,614 |
| ATYR PHARMA INC | COM NEW | 002120202 | — | 800,000 shares | $1,408,000 |
| LARIMAR THERAPEUTICS INC | COM | 517125100 | — | 200,000 shares | $1,310,000 |
| ENGENE HOLDINGS INC | COM | 29286M105 | — | 160,898 shares | $1,061,927 |
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | — | 325,000 shares | $1,053,000 |